Intuitive Surgical, Inc. Hits New 52-Week Low at $342.19

Intuitive Surgical, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 342.19 as of July 20, 2026. This decline marks a significant downturn for the company, which has experienced a 1-year performance drop of 15.59%, contrasting sharply with the S&P 500's gain of 18.21% during the same period. With a market capitalization of USD 160,753 million, Intuitive Surgical operates within the large-cap segment of the market. The company's price-to-earnings (P/E) ratio stands at 56.00, indicating a premium valuation relative to its earnings. Additionally, Intuitive Surgical has a price-to-book ratio of 9.02, reflecting its market valuation compared to its book value. Despite the current challenges, the company maintains a return on equity of 16.17%, showcasing its ability to generate profits from shareholders' equity. However, it is noteworthy that Intuitive Surgical does not offer a dividend yield, and its debt-to-equity ratio is reported at -0.33, suggesting a unique capital structure. As the stock navigates these market conditions, its performance metrics will be closely monitored by stakeholders.